Chapter 19: Cost-effectiveness of cervical cancer screening

This publication has 25 references indexed in Scilit:

• Cost-effectiveness of Extending Cervical Cancer Screening Intervals Among Women With Prior Normal Pap Tests
  Obstetrics & Gynecology, 2006
• Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies
  BMJ, 2006
• Evaluation of cervical screening strategies with adjunct high‐risk human papillomavirus testing for women with borderline or mild dyskaryosis
  International Journal of Cancer, 2005
• An alternative cost effectiveness analysis of ThinPrep in the Australian setting
  Australian and New Zealand Journal of Obstetrics and Gynaecology, 2005
• Cost-effectiveness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and Italy
  JNCI Journal of the National Cancer Institute, 2005
• The cost-effectiveness of human papillomavirus screening for cervical cancer
  The European Journal of Health Economics, 2005
• Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More
  Obstetrics & Gynecology, 2004
• Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries,
  Obstetrics & Gynecology, 2002
• Cost-Effectiveness of Cervical Cancer Screening: Comparison of Screening Policies
  JNCI Journal of the National Cancer Institute, 2002
• Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness
  European Journal Of Cancer, 2000